Onxeo Sa Stock Current Valuation
C4X Stock | EUR 0.11 0.01 8.33% |
Valuation analysis of Onxeo SA helps investors to measure Onxeo SA's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Onxeo SA's price fluctuation is out of control at this time. Calculation of the real value of Onxeo SA is based on 3 months time horizon. Increasing Onxeo SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Onxeo SA is useful when determining the fair value of the Onxeo stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Onxeo SA. Since Onxeo SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Onxeo Stock. However, Onxeo SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.11 | Real 0.095 | Hype 0.11 | Naive 0.11 |
The real value of Onxeo Stock, also known as its intrinsic value, is the underlying worth of Onxeo SA Company, which is reflected in its stock price. It is based on Onxeo SA's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Onxeo SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Onxeo SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Onxeo SA helps investors to forecast how Onxeo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Onxeo SA more accurately as focusing exclusively on Onxeo SA's fundamentals will not take into account other important factors: Onxeo SA Company Current Valuation Analysis
Onxeo SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Onxeo SA Current Valuation | 5.34 M |
Most of Onxeo SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Onxeo SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Onxeo SA has a Current Valuation of 5.34 M. This is 99.96% lower than that of the Healthcare sector and 99.88% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 99.97% higher than that of the company.
Onxeo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Onxeo SA's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Onxeo SA could also be used in its relative valuation, which is a method of valuing Onxeo SA by comparing valuation metrics of similar companies.Onxeo SA is currently under evaluation in current valuation category among related companies.
Onxeo Fundamentals
Return On Equity | -0.4 | |||
Return On Asset | -0.11 | |||
Operating Margin | (2.88) % | |||
Current Valuation | 5.34 M | |||
Shares Outstanding | 111.06 M | |||
Shares Owned By Insiders | 13.25 % | |||
Shares Owned By Institutions | 12.72 % | |||
Price To Earning | 50.90 X | |||
Price To Book | 0.48 X | |||
Price To Sales | 5.35 X | |||
Revenue | 4.06 M | |||
Gross Profit | 3.69 M | |||
EBITDA | (4.49 M) | |||
Net Income | (5.94 M) | |||
Cash And Equivalents | 24.46 M | |||
Cash Per Share | 0.29 X | |||
Total Debt | 9.91 M | |||
Debt To Equity | 0.31 % | |||
Current Ratio | 3.85 X | |||
Book Value Per Share | 0.27 X | |||
Cash Flow From Operations | (8.57 M) | |||
Earnings Per Share | (0.11) X | |||
Number Of Employees | 36 | |||
Beta | 1.89 | |||
Market Capitalization | 37.98 M | |||
Total Asset | 53.06 M | |||
Z Score | 1.8 | |||
Net Asset | 53.06 M |
About Onxeo SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Onxeo SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Onxeo SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Onxeo SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Onxeo SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Onxeo SA's short interest history, or implied volatility extrapolated from Onxeo SA options trading.
Pair Trading with Onxeo SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Onxeo SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onxeo SA will appreciate offsetting losses from the drop in the long position's value.Moving against Onxeo Stock
0.63 | NOVA | Novo Nordisk AS | PairCorr |
0.57 | DBPE | Xtrackers LevDAX | PairCorr |
0.55 | MBG | Mercedes Benz Group Earnings Call This Week | PairCorr |
0.51 | BZG2 | PT Bank Central | PairCorr |
The ability to find closely correlated positions to Onxeo SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Onxeo SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Onxeo SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Onxeo SA to buy it.
The correlation of Onxeo SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onxeo SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onxeo SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Onxeo SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Onxeo SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Onxeo Stock analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |